312 related articles for article (PubMed ID: 18287337)
1. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features.
Raizer JJ; Hwu WJ; Panageas KS; Wilton A; Baldwin DE; Bailey E; von Althann C; Lamb LA; Alvarado G; Bilsky MH; Gutin PH
Neuro Oncol; 2008 Apr; 10(2):199-207. PubMed ID: 18287337
[TBL] [Abstract][Full Text] [Related]
2. Survival and prognostic factors in patients with brain metastases from malignant melanoma.
Meier S; Baumert BG; Maier T; Wellis G; Burg G; Seifert B; Dummer R
Onkologie; 2004 Apr; 27(2):145-9. PubMed ID: 15138346
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
[TBL] [Abstract][Full Text] [Related]
4. Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic Control.
Alvarez-Breckenridge C; Giobbie-Hurder A; Gill CM; Bertalan M; Stocking J; Kaplan A; Nayyar N; Lawrence DP; Flaherty KT; Shih HA; Oh K; Batchelor TT; Cahill DP; Sullivan R; Brastianos PK
Oncologist; 2019 May; 24(5):671-679. PubMed ID: 30796152
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
8. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.
Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ
Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and impact of treatment in melanoma brain metastases: better prognosis for women?
Hofmann MA; Coll SH; Küchler I; Kiecker F; Wurm R; Sterry W; Trefzer U
Dermatology; 2007; 215(1):10-6. PubMed ID: 17587834
[TBL] [Abstract][Full Text] [Related]
11. Determinants of survival in patients with brain metastases from cutaneous melanoma.
Staudt M; Lasithiotakis K; Leiter U; Meier F; Eigentler T; Bamberg M; Tatagiba M; Brossart P; Garbe C
Br J Cancer; 2010 Apr; 102(8):1213-8. PubMed ID: 20372154
[TBL] [Abstract][Full Text] [Related]
12. Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade.
Milsch L; Gesierich A; Kreft S; Livingstone E; Zimmer L; Goebeler M; Schadendorf D; Schilling B
Eur J Cancer; 2018 Aug; 99():58-65. PubMed ID: 29906735
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
Morikawa A; Wang R; Patil S; Diab A; Yang J; Hudis CA; McArthur HL; Beal K; Seidman AD
Clin Breast Cancer; 2018 Oct; 18(5):353-361. PubMed ID: 29337140
[TBL] [Abstract][Full Text] [Related]
14. Extent of surrounding edema does not correlate with acute complications after radiosurgery for melanoma brain metastases.
Jardim A; Scott J; Drew Z; Foote MC; Sadasivan AP; Hall B; Olson SL; Shanker M; Pinkham MB
J Neurooncol; 2019 Dec; 145(3):581-585. PubMed ID: 31691060
[TBL] [Abstract][Full Text] [Related]
15. Cerebral metastases of cutaneous melanoma.
Gupta G; Robertson AG; MacKie RM
Br J Cancer; 1997; 76(2):256-9. PubMed ID: 9231928
[TBL] [Abstract][Full Text] [Related]
16. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma.
Eigentler TK; Figl A; Krex D; Mohr P; Mauch C; Rass K; Bostroem A; Heese O; Koelbl O; Garbe C; Schadendorf D;
Cancer; 2011 Apr; 117(8):1697-703. PubMed ID: 21472716
[TBL] [Abstract][Full Text] [Related]
17. Determinants of outcome in melanoma patients with cerebral metastases.
Fife KM; Colman MH; Stevens GN; Firth IC; Moon D; Shannon KF; Harman R; Petersen-Schaefer K; Zacest AC; Besser M; Milton GW; McCarthy WH; Thompson JF
J Clin Oncol; 2004 Apr; 22(7):1293-300. PubMed ID: 15051777
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
[TBL] [Abstract][Full Text] [Related]
19. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
[TBL] [Abstract][Full Text] [Related]
20. Predictors and survival in patients with melanoma brain metastases.
Bottoni U; Clerico R; Paolino G; Ambrifi M; Corsetti P; Calvieri S
Med Oncol; 2013 Mar; 30(1):466. PubMed ID: 23377924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]